Thompson Siegel & Walmsley LLC Sells 322,734 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Thompson Siegel & Walmsley LLC trimmed its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 4.6% in the fourth quarter, HoldingsChannel reports. The firm owned 6,633,146 shares of the pharmacy operator’s stock after selling 322,734 shares during the period. Thompson Siegel & Walmsley LLC’s holdings in Walgreens Boots Alliance were worth $61,887,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. HBK Sorce Advisory LLC increased its holdings in Walgreens Boots Alliance by 10.4% during the 4th quarter. HBK Sorce Advisory LLC now owns 12,591 shares of the pharmacy operator’s stock valued at $117,000 after purchasing an additional 1,188 shares in the last quarter. Achmea Investment Management B.V. increased its holdings in Walgreens Boots Alliance by 256.3% during the 4th quarter. Achmea Investment Management B.V. now owns 244,273 shares of the pharmacy operator’s stock valued at $2,279,000 after purchasing an additional 175,707 shares in the last quarter. Rakuten Securities Inc. increased its stake in shares of Walgreens Boots Alliance by 93.1% in the 4th quarter. Rakuten Securities Inc. now owns 463,001 shares of the pharmacy operator’s stock valued at $4,320,000 after buying an additional 223,185 shares during the period. Avantax Advisory Services Inc. increased its stake in shares of Walgreens Boots Alliance by 2.4% in the 4th quarter. Avantax Advisory Services Inc. now owns 49,896 shares of the pharmacy operator’s stock valued at $466,000 after buying an additional 1,186 shares during the period. Finally, Farther Finance Advisors LLC increased its stake in shares of Walgreens Boots Alliance by 31.4% in the 4th quarter. Farther Finance Advisors LLC now owns 7,661 shares of the pharmacy operator’s stock valued at $71,000 after buying an additional 1,830 shares during the period. 58.59% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

WBA has been the subject of several research reports. Bank of America lifted their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research note on Monday, January 13th. Truist Financial lowered their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research note on Friday, January 31st. Wolfe Research raised Walgreens Boots Alliance to a “hold” rating in a research note on Monday, February 24th. Deutsche Bank Aktiengesellschaft cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating and lowered their target price for the company from $11.00 to $9.00 in a research note on Friday, February 28th. Finally, Evercore ISI lifted their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research note on Monday, January 13th. Four analysts have rated the stock with a sell rating, eight have given a hold rating and two have issued a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $11.54.

Walgreens Boots Alliance Stock Performance

WBA stock opened at $11.20 on Thursday. The business’s 50-day moving average price is $10.75 and its two-hundred day moving average price is $9.74. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. The firm has a market cap of $9.68 billion, a PE ratio of -1.09, a P/E/G ratio of 1.31 and a beta of 0.62. Walgreens Boots Alliance, Inc. has a 1-year low of $8.08 and a 1-year high of $22.05.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.13. The firm had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company’s revenue for the quarter was up 7.6% on a year-over-year basis. During the same period in the previous year, the company posted $0.66 earnings per share. As a group, research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.